Serglycin is a novel adipocytokine highly expressed in epicardial adipose tissue

Biochemical and Biophysical Research Communications

Volumn 432, Issue 1, 2013, Pages 105-110

  Imoto Tsubakimoto, Hiroko ^a   Takahashi, Tomosaburo ^a   Ueyama, Tomomi ^a   Ogata, Takehiro ^a   Adachi, Atsuo ^a   Nakanishi, Naohiko ^a   Mizushima, Katsura ^a   Naito, Yuji ^a   Matsubara, Hiroaki ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Adipocytokine; Adipose tissue; Epicardium; Serglycin

Indexed keywords

ADIPOCYTOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR 2; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; SERGLYCIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN 3T3; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DNA MICROARRAY; EPICARDIAL ADIPOSE TISSUE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; INFLAMMATION; OMENTUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SUBCUTANEOUS FAT;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ADIPOKINES; ADIPOSE TISSUE; ANIMALS; CORONARY ARTERY DISEASE; HUMANS; INFLAMMATION; MICE; PERICARDIUM; PROTEOGLYCANS; TRANSCRIPTOME; TUMOR NECROSIS FACTOR-ALPHA; VESICULAR TRANSPORT PROTEINS;

EID: 84875365446     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.01.078     Document Type: Article

References (41)

1. Hubert H.B., Feinleib M., McNamara P.M., Castelli W.P. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983, 67:968-977.
2. Adams K.F., Schatzkin A., Harris T.B., Kipnis V., Mouw T., Ballard-Barbash R., Hollenbeck A., Leitzmann M.F. Overweight, obesity, and mortality in a large prospective cohort of persons 50-71years old. N. Engl. J. Med. 2006, 355:763-778.
3. Poirier P., Giles T.D., Bray G.A., Hong Y., Stern J.S., Pi-Sunyer F.X., Eckel R.H. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 1997, 113(2006):898-918.
4. Guzik T.J., Mangalat D., Korbut R. Adipocytokines - novel link between inflammation and vascular function?. J. Physiol. Pharmacol. 2006, 57:505-528.
5. Katagiri H., Yamada T., Oka Y. Adiposity and cardiovascular disorders: disturbance of the regulatory system consisting of humoral and neuronal signals. Circ. Res. 2007, 101:27-39.
6. Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Lett. 2006, 580:2917-2921.
7. Despres J.P., Lemieux I., Bergeron J., Pibarot P., Mathieu P., Larose E., Rodes-Cabau J., Bertrand O.F., Poirier P. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler. Thromb. Vasc. Biol. 2008, 28:1039-1049.
8. Hajer G.R., van Haeften T.W., Visseren F.L. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur. Heart J. 2008, 29:2959-2971.
9. Larsson B., Svardsudd K., Welin L., Wilhelmsen L., Bjorntorp P., Tibblin G. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13year follow up of participants in the study of men born in 1913. Br. Med. J. (Clin. Res. Ed.) 1984, 288:1401-1404.
10. Nakamura T., Kobayashi H., Yanagi K., Nakagawa T., Nishida M., Kihara S., Hiraoka H., Nozaki S., Funahashi T., Yamashita S., Kameda-Takemura K., Matsuzawa Y. Importance of intra-abdominal visceral fat accumulation to coronary atherosclerosis in heterozygous familial hypercholesterolaemia. Int. J. Obes. Relat. Metab. Disord. 1997, 21:580-586.
11. Morimoto C., Tsujita T., Okuda H. Norepinephrine-induced lipolysis in rat fat cells from visceral and subcutaneous sites: role of hormone-sensitive lipase and lipid droplets. J. Lipid Res. 1997, 38:132-138.
12. Wajchenberg B.L. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr. Rev. 2000, 21:697-738.
13. Mazurek T., Zhang L., Zalewski A., Mannion J.D., Diehl J.T., Arafat H., Sarov-Blat L., O'Brien S., Keiper E.A., Johnson A.G., Martin J., Goldstein B.J., Shi Y. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003, 108:2460-2466.
14. Baker A.R., Silva N.F., Quinn D.W., Harte A.L., Pagano D., Bonser R.S., Kumar S., McTernan P.G. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc. Diabetol. 2006, 5:1.
15. Cheng K.H., Chu C.S., Lee K.T., Lin T.H., Hsieh C.C., Chiu C.C., Voon W.C., Sheu S.H., Lai W.T. Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. Int. J. Obes. (Lond.) 2008, 32:268-274.
16. Iacobellis G., Pistilli D., Gucciardo M., Leonetti F., Miraldi F., Brancaccio G., Gallo P., di Gioia C.R. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine 2005, 29:251-255.
17. Teijeira-Fernandez E., Eiras S., Salgado Somoza A., Gonzalez-Juanatey J.R. Baseline epicardial adipose tissue adiponectin levels predict cardiovascular outcomes: a long-term follow-up study. Cytokine 2012, 60:674-680.
18. Ogata T., Ueyama T., Nomura T., Asada S., Tagawa M., Nakamura T., Takahashi T., Matsubara H., Oh H. Osteopontin is a myosphere-derived secretory molecule that promotes angiogenic progenitor cell proliferation through the phosphoinositide 3-kinase/Akt pathway. Biochem. Biophys. Res. Commun. 2007, 359:341-347.
19. Adachi A., Takahashi T., Ogata T., Imoto-Tsubakimoto H., Nakanishi N., Ueyama T., Matsubara H. NFAT5 regulates the canonical Wnt pathway and is required for cardiomyogenic differentiation. Biochem. Biophys. Res. Commun. 2012, 426:317-323.
20. Nakanishi N., Takahashi T., Ogata T., Adachi A., Imoto-Tsubakimoto H., Ueyama T., Matsubara H. PARM-1 promotes cardiomyogenic differentiation through regulating the BMP/Smad signaling pathway. Biochem. Biophys. Res. Commun. 2012, 428:500-505.
21. Nakajima N., Takahashi T., Kitamura R., Isodono K., Asada S., Ueyama T., Matsubara H., Oh H. MicroRNA-1 facilitates skeletal myogenic differentiation without affecting osteoblastic and adipogenic differentiation. Biochem. Biophys. Res. Commun. 2006, 350:1006-1012.
22. Ogata T., Ueyama T., Isodono K., Tagawa M., Takehara N., Kawashima T., Harada K., Takahashi T., Shioi T., Matsubara H., Oh H. MURC, a muscle-restricted coiled-coil protein that modulates the Rho/ROCK pathway, induces cardiac dysfunction and conduction disturbance. Mol. Cell. Biol. 2008, 28:3424-3436.
23. Tagawa M., Ueyama T., Ogata T., Takehara N., Nakajima N., Isodono K., Asada S., Takahashi T., Matsubara H., Oh H. MURC, a muscle-restricted coiled-coil protein, is involved in the regulation of skeletal myogenesis. Am. J. Physiol. Cell Physiol. 2008, 295:C490-498.
24. Cristancho A.G., Lazar M.A. Forming functional fat: a growing understanding of adipocyte differentiation. Nat. Rev. Mol. Cell Biol. 2011, 12:722-734.
25. Iacobellis G., Bianco A.C. Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features. Trends Endocrinol. Metab. 2011, 22:450-457.
26. Cherian S., Lopaschuk G.D., Carvalho E. Cellular cross-talk between epicardial adipose tissue and myocardium in relation to the pathogenesis of cardiovascular disease. Am. J. Physiol. Endocrinol. Metab. 2012, 303:E937-949.
27. Kleemann R., Zadelaar S., Kooistra T. Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc. Res. 2008, 79:360-376.
28. Kolset S.O., Pejler G. Serglycin: a structural and functional chameleon with wide impact on immune cells. J. Immunol. 2011, 187:4927-4933.
29. Kolset S.O., Tveit H. Serglycin-structure and biology. Cell. Mol. Life Sci. 2008, 65:1073-1085.
30. O'Rourke R.W., White A.E., Metcalf M.D., Olivas A.S., Mitra P., Larison W.G., Cheang E.C., Varlamov O., Corless C.L., Roberts C.T., Marks D.L. Hypoxia-induced inflammatory cytokine secretion in human adipose tissue stromovascular cells. Diabetologia 2011, 54:1480-1490.
31. Zernichow L., Abrink M., Hallgren J., Grujic M., Pejler G., Kolset S.O. Serglycin is the major secreted proteoglycan in macrophages and has a role in the regulation of macrophage tumor necrosis factor-alpha secretion in response to lipopolysaccharide. J. Biol. Chem. 2006, 281:26792-26801.
32. Maury E., Noel L., Detry R., Brichard S.M. In vitro hyperresponsiveness to tumor necrosis factor-alpha contributes to adipokine dysregulation in omental adipocytes of obese subjects. J. Clin. Endocrinol. Metab. 2009, 94:1393-1400.
33. Berg A.H., Scherer P.E. Adipose tissue, inflammation, and cardiovascular disease. Circ. Res. 2005, 96:939-949.
34. Suganami T., Tanaka M., Ogawa Y. Adipose tissue inflammation and ectopic lipid accumulation [Review]. Endocr. J. 2012, 59:849-857.
35. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 112:1796-1808.
36. Curat C.A., Miranville A., Sengenes C., Diehl M., Tonus C., Busse R., Bouloumie A. From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 2004, 53:1285-1292.
37. Bruun J.M., Lihn A.S., Pedersen S.B., Richelsen B. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J. Clin. Endocrinol. Metab. 2005, 90:2282-2289.
38. Corcoran T.B., Engel A., Sakamoto H., O'Callaghan-Enright S., O'Donnell A., Heffron J.A., Shorten G. The effects of propofol on lipid peroxidation and inflammatory response in elective coronary artery bypass grafting. J. Cardiothorac. Vasc. Anesth. 2004, 18:592-604.
39. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 1999, 340:115-126.
40. Stoll L.L., Denning G.M., Weintraub N.L. Potential role of endotoxin as a proinflammatory mediator of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2004, 24:2227-2236.
41. Weber C., Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat. Med. 2011, 17:1410-1422.